secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bluejay Diagnostics, Inc. (BJDX)
CIK:        0001704287
Form:       8-K
Filed at:   2024-01-02T23:59:59+00:00
Accession:  0001213900-24-000317
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bluejay Diagnostics closes $3.5M public offering of common stock and warrants
-----------------------------------------------------------------------------

- 2,692,308 units sold at $1.30/unit: one share (or pre-funded warrant) plus one warrant to buy one share.
- Gross proceeds ~$3.5M; net proceeds to fund FDA approval, clinical studies, R&D, and working capital.
- Warrants exercisable at $1.30/share for 5 years; pre-funded warrants exercisable at $0.0001.
- H.C. Wainwright as placement agent; 7% cash fee and 188,462 placement agent warrants at $1.625.
- Offering closed Jan 2, 2024; registered on Form S-1 effective Dec 27, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1704287/000121390024000317/0001213900-24-000317-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1704287/000121390024000317/ea191005-8k_bluejay.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-000317

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer